Filing Details
- Accession Number:
- 0000899243-18-002046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-25 20:12:00
- Reporting Period:
- 2018-01-23
- Accepted Time:
- 2018-01-25 20:12:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1631574 | Wave Life Sciences Ltd. | WVE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657675 | Chandra Vargeese | C/O Wave Life Sciences Ltd., 733 Concord Ave. Cambridge MA 02138 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-01-23 | 2,000 | $2.48 | 11,800 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-01-23 | 2,000 | $40.00 | 9,800 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2018-01-23 | 17,500 | $0.00 | 27,300 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Option (right to buy) | Disposition | 2018-01-23 | 2,000 | $0.00 | 2,000 | $2.48 |
| Ordinary Shares | Share Option (right to buy) | Acquisiton | 2018-01-23 | 35,000 | $0.00 | 35,000 | $40.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 154,542 | 2025-03-10 | No | 4 | M | Direct | |
| 35,000 | 2028-01-23 | No | 4 | A | Direct |
Footnotes
- The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017.
- The incentive share option initially represented a right to purchase a total of 158,042 ordinary shares, 25% of which became exercisable on August 1, 2015, and the remaining shares vest in 36 equal monthly installments thereafter.
- Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022.
- The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022.
Billionaire Hedge Funds
